Do not Miss Rare and Treatable Cause of Early-Onset Hemolytic Uremic Syndrome: Cobalamin C Deficiency
暂无分享,去创建一个
[1] K. Frees,et al. Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic Syndrome. , 2018, Journal of the American Society of Nephrology : JASN.
[2] D. Trevisanuto,et al. Anemia and transfusion in the neonate. , 2016, Seminars in fetal & neonatal medicine.
[3] J. Benoist,et al. Adult-onset renal thrombotic microangiopathy and pulmonary arterial hypertension in cobalamin C deficiency , 2015, The Lancet.
[4] M. Baumgartner,et al. Nephrotic syndrome and thrombotic microangiopathy caused by cobalamin C deficiency , 2015, Pediatric Nephrology.
[5] R. Coppo,et al. An international consensus approach to the management of atypical hemolytic uremic syndrome in children , 2015, Pediatric Nephrology.
[6] G. Ardissino,et al. Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome: a report of 10 cases. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] M. Baumgartner,et al. Clinical presentation and outcome in a series of 88 patients with the cblC defect , 2014, Journal of Inherited Metabolic Disease.
[8] S. A R,et al. Role of absolute reticulocyte count in evaluation of pancytopenia-a hospital based study. , 2014, Journal of clinical and diagnostic research : JCDR.
[9] L. Doucet,et al. Adult-onset eculizumab-resistant hemolytic uremic syndrome associated with cobalamin C deficiency. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] A. Losito,et al. Combined Pulmonary Hypertension and Renal Thrombotic Microangiopathy in Cobalamin C Deficiency , 2013, Pediatrics.
[11] A. Iolascon,et al. Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach , 2012, Haematologica.
[12] S. Testa,et al. Neonatal atypical hemolytic uremic syndrome due to methylmalonic aciduria and homocystinuria , 2012, Pediatric Nephrology.
[13] K. Hsiao,et al. Mutation spectrum of MMACHC in Chinese patients with combined methylmalonic aciduria and homocystinuria , 2010, Journal of Human Genetics.
[14] M. Baumgartner,et al. Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype–phenotype correlations , 2009, Human mutation.
[15] G. Uziel,et al. Spectrum of MMACHC mutations in Italian and Portuguese patients with combined methylmalonic aciduria and homocystinuria, cblC type. , 2008, Molecular genetics and metabolism.
[16] C. Greenberg,et al. Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder , 2007, Pediatric Nephrology.
[17] C. Morel,et al. Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations. , 2006, Molecular genetics and metabolism.
[18] E. Shoubridge,et al. Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type , 2006, Nature Genetics.
[19] T. Suormala,et al. Prenatal and postnatal treatment in cobalamin C defect. , 2005, The Journal of pediatrics.
[20] P. Francis,et al. An infant with methylmalonic aciduria and homocystinuria (cblC) presenting with retinal haemorrhages and subdural haematoma mimicking non-accidental injury , 2004, European Journal of Pediatrics.
[21] T. Kind,et al. Cobalamin C disease presenting as hemolytic-uremic syndrome in the neonatal period. , 2002, Journal of pediatric hematology/oncology.